RSS News Feeds
Day High: 38.75
Day Low: 37.21
11:40 AM ET Jan 30, 2015
Delayed at least 20 min., by eSignal.
We are committed to serving the best interests of our shareholders. You will find key shareholder information and financial reports available to help put Tetraphase Pharmaceuticals's financial performance into perspective.
Dec 17, 2014
Tetraphase Announces Positive Top-line Results from Phase 3 IGNITE 1 Clinical Trial of Eravacycline in Complicated Intra-abdominal Infections
Dec 15, 2014
Tetraphase Pharmaceuticals Added to NASDAQ Biotechnology Index